UCLA Journal of Radiation Oncology_SS 2025_FOR PRINT - Flipbook - Page 53
RESIDENT WINS
Beth Neilsen, MD, PhD / PGY-5
Dr. Neilsen has accepted a position at Stanford as a Clinical Assistant Professor.
Dr. Neilsen’s ASTRO abstract, Genomic and Transcriptomic Pro昀椀ling of
Radiation Resistant, Locally Recurrent Prostate Cancer (under Dr. Amar Kishan),
was selected for an oral presentation and received the Annual Meeting Travel
Award in the biology.
.
Travis Courtney, MD, MS / PGY-4
Dr. Courtney had the following recent publications:
Courtney PT, Dong H, Lao Y, Pham J, Lauria M, Chu FI, Krupien AJ, Valle
LF, Low DA, Lamb J, Steinberg ML, Qi XS, Cao M, Kishan AU. Dosimetric
Comparison of MRI-Guided Versus Reduced Margin CT-Guided Stereotactic
Body Radiotherapy for Localized Prostate Cancer: Post-Hoc Analysis of a Phase
III Trial. Int J Radiat Oncol Biol Phys. 2025 Jun 5:S03603016(25)00553-X. doi:
10.1016/j.ijrobp.2025.05.066. Epub ahead of print. PMID: 40482729.
Courtney PT, Venkat PS, Shih YT, Chang AJ, Lee A, Steinberg ML, Raldow
AC. Cost Effectiveness of Pembrolizumab With Chemoradiotherapy for Locally
Advanced Cervical Cancer. JAMA Netw Open. 2025 Mar 3;8(3):e250033.
doi:10.1001/jamanetworkopen.2025.0033. PMID: 40036034; PMCID:
PMC11880949.
Dr. Courtney had multiple abstracts accepted including the following as an oral
presentation: Courtney PT, Pham J, Kalbasi TR, Karasik DS, Valle LF, Casado M,
Ghafarian M, Calais J, Sung KH, Wu TC, Lamb J, Cao M, Steinberg ML, Kishan
AU. Acute Toxicity Following Dose-Escalated MRI-guided SBRT versus Adapted
Dose-Painted MRI-Guided SBRT: A Pooled Comparison of Prospective Trials.
September 29, 2025.
The PULS-Pal trial (NCT06572423), on which Dr. Courtney is the PI, reached 50%
of target enrollment. The ILLUSION trial (NCT06995053), on which he is the CoPI, opened for enrollment. Additionally, Dr. Courtney was selected to participate in
the 2025 ASCO/AACR Methods in Clinical Cancer Research Workshop.
53
